Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | CASP7 | P55210 | 1/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.32 |
| ▸ | HTR2A | P28223 | 3/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4637099 | 0.78 | ESR1 (0.42) | ALDH1A1TSHRCYP2C19SMN1; SMN2CYP3A4 | |
| SCHEMBL28555034 | 0.77 | TSHR (0.34) | ALDH1A1TSHRCYP2C19SMN1; SMN2CYP3A4 | |
| SCHEMBL29295702 | 0.77 | ADRB2 (0.42) | ALDH1A1TSHRCYP2C19CYP3A4CASP1 | |
| SCHEMBL11437594 | 0.77 | TSHR (0.62) | ALDH1A1TSHRCYP2C19HSD17B10SMN1; SMN2 | |
| SCHEMBL111291 | 0.75 | TSHR (0.59) | ALDH1A1TSHRCYP2C19HSD17B10SMN1; SMN2 | |
| SCHEMBL7868990 | 0.75 | TAAR1 (0.52) | ALDH1A1TSHRSMN1; SMN2CYP3A4ALOX15 | |
| SCHEMBL3820403 | 0.75 | TSHR (0.59) | ALDH1A1TSHRCYP2C19HSD17B10SMN1; SMN2 | |
| SCHEMBL7192197 | 0.74 | ALDH1A1 (0.46) | ALDH1A1CYP2C19 | |
| SCHEMBL10600302 | 0.74 | CA12 (0.39) | ALDH1A1CYP2C19SMN1; SMN2CA1CA2 | |
| SCHEMBL8089363 | 0.74 | KDM4E (0.44) | ALDH1A1TSHRCYP2C19HSD17B10CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7847108-B2 | such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms | BAYER CROPSCIENCE AG (DE) | 2010-12-07 | — | — | US | disclosed |
| US-7847108-B2 | such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms | BAYER CROPSCIENCE AG (DE) | 2010-12-07 | — | — | US | disclosed |
| US-7847108-B2 | such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms | BAYER CROPSCIENCE AG (DE) | 2010-12-07 | — | — | US | disclosed |
| EP-1599460-B1 | OXATHIIN CARBOXAMIDE | BAYER CROPSCIENCE AG (DE) | 2007-11-07 | — | — | EP | disclosed |
| EP-1599460-B1 | OXATHIIN CARBOXAMIDE | BAYER CROPSCIENCE AG (DE) | 2007-11-07 | — | — | EP | disclosed |
| US-20070004793-A1 | such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2007-01-04 | — | — | US | disclosed |
| US-20070004793-A1 | such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2007-01-04 | — | — | US | disclosed |
| US-20070004793-A1 | such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2007-01-04 | — | — | US | disclosed |
| EP-1599460-A2 | OXATHIIN CARBOXAMIDE | Bayer CropScience Aktiengesellschaft (DE) | 2005-11-30 | — | — | EP | disclosed |
| WO-2004072023-A2 | OXATHIIN CARBOXAMIDE | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2004-08-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070004793-A1 | such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms | Q6ZSR9, PFAS, NIT2 | ALDH1A1 1804/4885TSHR 1970/4885CYP2C19 2799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.